Terms: = Lung cancer AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
30 results:
1. Downregulated circ_0001681 Predicts the Occurrence and Malignant Development of lung Carcinoma via Negatively Modulating miR-567.
Li M; Mao C; Li W; Xia W; Li K; Xu R
Ann Clin Lab Sci; 2023 Nov; 53(6):881-889. PubMed ID: 38182148
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer.
Győrffy B
Br J Pharmacol; 2024 Feb; 181(3):362-374. PubMed ID: 37783508
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative serum bilirubin is an independent prognostic factor for curatively resected esophageal squamous cell carcinoma.
Huang X; Chen Y; Yang H; Wang R; Chen Z
BMC Cancer; 2023 Jul; 23(1):706. PubMed ID: 37507653
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation.
Kuang M; Zhou Z; Lu Z; Shen W; Ge H; Tao X; Zhao Y; Zhuge L; Sun Y; Ji D; Zhang H
Clin Respir J; 2023 Mar; 17(3):148-156. PubMed ID: 36710485
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies.
Tanaka T; Yoshida T; Masuda K; Takeyasu Y; Shinno Y; Matsumoto Y; Okuma Y; Goto Y; Horinouchi H; Yamamoto N; Ohe Y
Respir Investig; 2023 Jan; 61(1):74-81. PubMed ID: 36460585
[TBL] [Abstract] [Full Text] [Related]
6. Construction and Validation of Early Warning Model of lung cancer Based on Machine Learning: A Retrospective Study.
Ye S; Pan J; Ye Z; Cao Z; Cai X; Zheng H; Ye H
Technol Cancer Res Treat; 2022; 21():15330338221136724. PubMed ID: 36380607
[No Abstract] [Full Text] [Related]
7. PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types.
Shang X; Zhang W; Zhang X; Yu M; Liu J; Cheng Y; Cheng B
Front Immunol; 2022; 13():991091. PubMed ID: 36248841
[TBL] [Abstract] [Full Text] [Related]
8. Pathological Stage N1 Limited-Stage Small-Cell lung cancer Patients Can Benefit From Surgical Resection.
Yu L; Xu J; Qiao R; Han B; Zhong H; Zhong R
Clin Lung Cancer; 2023 Jan; 24(1):e1-e8. PubMed ID: 36085281
[TBL] [Abstract] [Full Text] [Related]
9. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in lung Adenocarcinoma].
Ke J; Cui J; Yang X; Du X; Ma B; Yu L
Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
[TBL] [Abstract] [Full Text] [Related]
10. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X
J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150
[TBL] [Abstract] [Full Text] [Related]
11. PTEN Loss as a Predictor of Tumor Heterogeneity and Poor prognosis in Patients With EGFR-mutant Advanced Non-small-cell lung cancer Receiving Tyrosine Kinase Inhibitors.
Ferrara MG; Martini M; D'Argento E; Forcella C; Vita E; Di Noia V; Sperduti I; Bilotta M; Ribelli M; Damiano P; Cannella A; Stefani A; Pilotto S; Carbone C; Piro G; Milella M; Tortora G; Bria E
Clin Lung Cancer; 2021 Jul; 22(4):351-360. PubMed ID: 33558194
[TBL] [Abstract] [Full Text] [Related]
12. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With cancer.
Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
[TBL] [Abstract] [Full Text] [Related]
13. Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with
Qin Y; Yu M; Zhou L; Jiang L; Huang M
Immunotherapy; 2020 Mar; 12(4):223-227. PubMed ID: 32156177
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
[TBL] [Abstract] [Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio and risk of lung cancer mortality in a low-risk population: A cohort study.
Kang J; Chang Y; Ahn J; Oh S; Koo DH; Lee YG; Shin H; Ryu S
Int J Cancer; 2019 Dec; 145(12):3267-3275. PubMed ID: 31454064
[TBL] [Abstract] [Full Text] [Related]
16. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
[TBL] [Abstract] [Full Text] [Related]
17. [Correlation between Plasma D-dimer Count and Features of
Non-small Cell lung cancer].
Song X; Wang F; Shen H; Li J; Hu T; Yang Z; Zhou Y; Shi Q
Zhongguo Fei Ai Za Zhi; 2019 Mar; 22(3):151-156. PubMed ID: 30909994
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of Histological Grade in Resected lung-invasive Adenocarcinoma.
Yasukawa M; Ohbayashi C; Kawaguchi T; Kawai N; Nakai T; Sawabata N; Taniguchi S
Anticancer Res; 2019 Mar; 39(3):1491-1500. PubMed ID: 30842187
[TBL] [Abstract] [Full Text] [Related]
19. Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial-Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells.
Wang J; Yang W; Wang T; Chen X; Wang J; Zhang X; Cai C; Zhong B; Wu J; Chen Z; Xiang AP; Huang W
Sci Rep; 2018 Apr; 8(1):5422. PubMed ID: 29615660
[TBL] [Abstract] [Full Text] [Related]
20. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell lung cancer Harboring EGFR Mutations.
Suh KJ; Keam B; Kim M; Park YS; Kim TM; Jeon YK; Kim DW; Chung DH; Kim YW; Heo DS
Clin Lung Cancer; 2016 Jul; 17(4):245-252.e1. PubMed ID: 26719155
[TBL] [Abstract] [Full Text] [Related]
[Next]
